RegeneCure Starts Worldwide Veterinary Distribution of BoneCure Membrane Implant for Acceleration of Fracture Healing and Carpal Arthrodesis

(PresseBox) ( Jerusalem, Israel, )
RegeneCure Ltd., a developer of novel regenerative membrane implant technology for the treatment of human and animal bone fractures, announced today that the company has started to distribute its BoneCure® Membrane product to the veterinary market around the world.

The distribution follows the successful results of a recent clinical study in several EC countries and Israel. BoneCure Membrane was used by European Veterinary Surgeons in pets for the following indications: non-union, large bone gaps, arthrodesis and severe fractures. The study showed that the healing time was about 40 percent quicker than normally observed using current Standard of Care therapies.

"Based on the outstanding safety and efficacy results of our clinical and pre-clinical studies, we expect BoneCure to enable veterinary surgeons to treat a larger number of severe fracture types and to significantly reduce the healing time and complication rate," said Moshe Tzabari, CEO of RegeneCure.

Distribution with dealers is now underway throughout Europe, Asia, Australia and the United States.

The use of the BoneCure Membrane for carpal arthrodesis is a major breakthrough in the surgery of companion animals that offers many advantages over the traditional "Gold Standard" procedure of harvesting an autogenous bone graft. This procedure, described at the BoneCure website, prevents patient morbidity and pain, reduces the risks of infection and fracture at the donor site, saves operating time and eliminates the need for a second incision.

RegeneCure's major distributor in Europe, Eickemeyer Veterinary Equipment, is organizing a practical two day course called "Small Animal Arthrodesis" on September 27 -28, 2013 at the Eickemeyer Centre for Veterinary Continuing Education, Tuttlingen, Germany. The course will be conducted by Ignacio Calvo, Ldo Vet, CertSAS, MRCVS, Head of Small Animal Orthopaedic Surgery, University of Glasgow, and Michael Farrell, BVetMed, CertVA, CertSAS, MRCVS, Senior Surgeon, Fitzpatrick Referrals. The course participants will develop theoretical and practical clinical decision-making skills about how and when to perform arthrodesis.

About BoneCure

RegeneCure's regenerative BoneCure membrane implant is cationic and has a microporous surface. Due to its osteoconductive stimulation, the membrane optimizes proliferation and differentiation of the MSCs into bone tissue in the area of need. This helps promote rapid bone healing by Guided Bone Regeneration.

The BoneCure membrane is thin and flexible, drillable and easily sutured in the treated area. It is easy to use in orthopedic surgery and requires no special surgical knowledge or preparation prior to use.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to